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INTRODUCTION
In many disease states, biological 
changes occur that indicate disease 
progression. For example, protein 
from cancer patients is commonly 
observed with an increased amount 
of the sugar fucose. Fucose levels are 
often elevated even before cancer 
symptoms are present; thus, fucose is 
an important indicator that a patient 
has cancer. The goal of this research 
is to develop a simple test for fucose 
levels to assist with early detection 
of cancer. This research involves 
preliminary tests to detect fucose at 
very low levels. These rapid methods 
could potentially be used in clinical 
tests for patients who are at risk. 
Two instrumental methods are also 
described, which provide sensitive 
and accurate quantitative results to 
verify the rapid methods.
BACKGROUND/METHODS
Diagnosing cancer in the early 
stages can be vital for improving 
patient treatment and survival rates. 
Significant research shows that 
biomarkers, or indicators of certain 
biological states, can be used to 
determine when cancer is present 
or has metastasized.1 Biomarkers 
like fucose are often detectable at 
the very early stages of cancer,2 so 
investigating these biomarkers is 
a growing field that is beneficial 
to patients at all stages of cancer 
diagnosis and treatment. Thus, the 
goal of this project is to develop quick, 
simple methods for detecting and 
quantifying fucose. These biomarker 
detection techniques can hopefully be 
applied beyond the laboratory and in a 
clinical setting, where a quick and easy 
method to determine fucosylation is 
vital to cancer prognosis. 
Proteins in the human body 
undergo numerous changes after they 
are produced in the cells. Glycosylation, 
or the addition of sugars to proteins, 
is ubiquitous in human proteins. 
Protein glycosylation is important 
for regulating cellular signaling, cell 
differentiation and has proven to 
be a biomarker for certain disease 
states.3,4 Changes in glycosylation 
occur in a variety of diseases, ranging 
from cancer to cystic fibrosis.5 For 
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example, elevated fucose levels on 
glycoproteins is linked to human 
hepatocellular carcinoma and even 
breast cancer.6,7 Measuring changes in 
fucosylation is a vital diagnostic tool 
for early cancer detection; changes in 
sugars often occur before cancer has 
fully developed.8 
Four analytical techniques were 
utilized to study and quantify fucose. 
The group investigated two common 
color-change reactions for detecting 
sugars. Colorimetric indicators are 
useful because the amount of sugar 
in a sample can easily be visualized 
without extra equipment. The first 
rapid method uses phenol and sulfuric 
acid. When added to a sugar solution, 
these compounds create a yellow 
dye; the shade of yellow depends 
upon the sugar concentration. This 
reaction was central to the Yellow 
Card method, in which a yellow scale 
was designed for visual determination 
of fucose concentration.  Potassium 
permanganate also reacts with 
reducing sugars to produce a 
color change that indicates fucose 
concentration. This Colorized Reducing 
Sugar (CRS) test was the second 
simple method. Two instrumental 
techniques were also chosen to 
accurately quantify fucose: High 
Performance Liquid Chromatography 
with Pulsed Amperometric Detection 
and Liquid Chromatography with 
Mass Spectrometry.  
It is necessary to study fucose at 
concentrations that are biologically 
relevant to ensure that experiments 
in the lab would be viable as clinical 
tests. Although these studies work 
with pure fucose rather than blood or 
serum samples, the fucose solutions 
were prepared based on characteristic 
fucose levels in the body. The group 
designated three classes based on 
fucose levels typical of oral cancer 
development. A normal, or cancer-
free, individual would have fucose 
levels at 800 μM; precancerous levels 
are at 1200 μM; the threshold for 
cancer is at 1600 μM.9 Experiments 
were designed using this classification 
system.
All methods were tested in the 
range stated above for preliminary 
experiments. Two test samples of 
fucose were also analyzed by each 
method. One group member prepared 
fucose solutions at concentrations of 
933 μM and 1314 μM. These samples 
were regarded as “unknown,” as the 
individuals testing these samples did 
not know their concentrations. The 
“unknown” samples were analyzed 
with each method. Experimental 
design is described below.
Rapid Methods 
The simple Yellow Card method 
is based on the colorization of sugar 
solutions upon addition of phenol 
and sulfuric acid. In the reaction, 
each monosaccharide molecule is 
dehydrated by the acid, forming 
a furfural derivative. The furfural 
derivative then condenses with two 
molecules of phenol to form a yellow 
dye molecule. The result is that one 
molecule of yellow dye is formed for 
each molecule of sugar in the solution. 
More concentrated sugar solutions, 
therefore, produce more intense 
yellow coloring. 
The color change occurs in all 
carbohydrate solutions, and only a 
small amount of fucose was available 
for experimentation, so experiments 
were performed with other sugars 
before testing methods on fucose 
solutions. Galactose is very similar 
to fucose, so it was chosen for the 
initial colorization experiments. 
Galactose solutions in a linear range 
of concentrations (200 μM to 2000 
μM) were prepared and reacted with 
phenol and sulfuric acid. The resulting 
solutions ranged in color from nearly 
clear to golden yellow. The experiment 
was then performed on fucose 
solutions, producing a similar range 
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of yellow hues. The 800 μM, 1200 μM, 
and 1600 μM fucose solutions were 
visibly distinguishable, suggesting 
that this range of concentrations 
would be useful for visual distinction 
between normal and elevated serum 
fucosylation levels.  
To develop the actual Yellow Card, 
fucose solutions of 800 μM, 1200 μM, 
and 1600 μM concentrations were 
reacted with phenol and sulfuric acid 
in identical vials, and their yellow hues 
were matched to color swatches from 
paint manufacturers. A pale yellow 
color matched the 800 μM solution and 
two darker shades of yellow matched 
the 1200 μM and 1600 μM solutions. 
These three colors are included in the 
tricolored “Yellow Card” and serve as 
references when estimating fucose 
concentrations (Figure 1).
The Colorized Reducing Sugar 
(CRS) test utilizes an oxidation-
reduction reaction in which the 
sugar’s aldehyde group is oxidized to 
a carboxylic acid and permanganate is 
reduced to manganese. Permanganate 
is purple in solution, while manganese 
is colorless. Solutions are colorized 
by the permanganate indicator, 
but each molecule of sugar in the 
solution removes some of the purple 
color. The color of the resulting 
solution, therefore, depends upon 
concentration of the sugar. The 
800μM fucose solution produced a 
maroon color, 1200μM fucose solution 
produced a burnt-orange color, and 
1600μM fucose solution produced a 
caramel-brown (Figure 2). 
Multiple sugars, including glucose, 
mannose, and galactose were tested as 
model systems for fucose. These were 
analyzed in the same concentration 
range and the same method was 
used as was used with fucose. All of 
the sugars produced similar colors 
when treated with indicator, but the 
color change occurred more rapidly 
for some sugars. Mannose reacted 
the fastest: the 1600μM sample 
turned brown within five minutes, 
then glucose—producing the caramel 
color in 10 minutes, and galactose 
was slowest—it required 50 minutes 
for the 1600μM sample to yield the 
caramel color (Figures 3-5). 
Variables such as concentration 
of sugar, volume of potassium 
permanganate, and time of heating 
were tested; it was determined 
that the concentration range that 
displays a color variation was from 
about 700μM to 1800μM (700μM 
being the lower limit of detection). 
Indicator (potassium permanganate) 
Figure 1. (left) Fucose solutions after 
treatment with phenol and sulfuric acid are 
placed on white backgrounds and can be seen 
to match the correct sections of the Yellow 
Card.  The colors included in the tricolored 
care are, from left to right, Honey Pot (ACE), 
Yellow Brick Road (ACE), and Citrus (Behr).
Figure 2. (above) Fucose, 15µL Indicator, 
800μM,	1200μM,1600μM	left	to	right,	30	min.
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volume affected the color change 
slightly. Solution colors were more 
distinguishable and darker when 
higher volumes of indicator were 
applied (Figure 6). Heating time 
affected results greatly—reaction rate 
increased as time on the heat source 
increased. Optimal results were 
obtained when fucose solutions were 
heated for one minute on a 90°C heat 
source, then removed and immediately 
treated with the indicator.  The color 
of the resulting solutions changed 
over time, and it was determined that 
different fucose concentrations were 
most distinguishable when observed 
20-30 minutes after addition of the 
indicator. Because the color change 
occurs for any reducing sugar, only 
pure fucose solutions were utilized for 
quantitative experiments.
Instrumental Methods
Although the simple methods 
stated above are quick, they do not 
have the quantitative capability of 
an instrumental technique. Thus, to 
explore more quantitative techniques, 
two instrumental methods were 
applied that provide sensitive and 
quantitative results. 
High performance liquid 
chromatography with pulsed 
amperometric detection (HPLC-
PAD) is a highly sensitive method 
for separating and detecting the 
components of a solution.  This 
method utilizes an anion exchange 
column, separating fucose through 
interactions of its anionic forms with 
the substrate of the column.  Different 
sugars have varying affinities for 
the column; thus move through it at 
different rates, and leave the column 
at specific times. Knowing these times 
for fucose allowed for identification 
and accurate quantitation.
Pulsed amperometric detection 
(PAD) was used with HPLC to 
detect fucose electrochemically. 
Amperometry was used with three 
electrodes to drive an electrochemical 
reaction. One of the electrodes is 
the working electrode, where the 
electrolysis takes place. The second 
electrode, the counter electrode, 
allows for the flow of current by 
acting as an “electron sink”.  For work 
with pulsed amperometric detection, 
a third non-polarizable electrode, 
the reference electrode, was needed 
so that a comparison between the 
changes in current could be measured. 
The change in current corresponded 
to the concentration of fucose in a 
Figure 3. Mannose, 20µL Indicator, 800, 
1000,	1200,	1400,	1600μM	left	to	right,	5	
min.
Figure 4. Glucose, 20µL Indicator, 800, 1000, 
1200,	1400,	1600μM	left	to	right,	10	min.
Figure 5. Galactose, 20µL Indicator, 800, 
1000,	1200,	1400,	1600μM	left	to	right,	50	
min.
Figure	 6.	 Fucose,	 20	 μL	 Indicator,	 left	 to	
right:	800	μM,	1200	μM,	1600	μM,	30	minute	
reaction time. A higher volume of indicator 
improved the reaction and made the three 
concentrations of fucose more visually 
distinguishable.
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sample. This method was applied 
to the samples run on the rapid 
colorimetric methods to confirm the 
accuracy of the results.
Quantitation by HPLC-PAD was 
done using a calibration curve as 
an external standard. Five fucose 
solutions (2000 μM, 1000 μM, 500 
μM, 250 μM, and 125 μM) were made 
by serial dilution.  Each solution was 
analyzed by HPLC-PAD three times, 
producing chromatograms (Figure 7). 
Literature relevant to the detection of 
simple carbohydrates using HPLC-PAD 
was consulted to select the optimal 
amperometric conditions. The fucose 
peak areas from the chromatograms 
were plotted versus concentration, 
and linear regression curve was 
made to fit the data. This produced a 
standard curve for the extrapolation of 
concentrations of unknown samples.
Along with HPLC-PAD, liquid 
chromatography-mass spectrometry 
(LC-MS) was used to verify the results 
of the rapid methods. With HPLC-PAD, 
separation occurs in the liquid phase 
inside a column. However, with LC-
MS, compounds were separated by 
an amino column. Optimal separation 
was produced by 
a mobile phase 
containing 60% 
ACN and 40% H2O.
M a s s 
spectrometry was 
used as to identify 
and quantify 
fucose after liquid 
chromatography. 
MS provides 
m a s s - s p e c i f i c 
information about 
compounds, which 
can be helpful for 
analysis. Utilizing 
e l e c t r o s p r a y 
ionization mass 
s p e c t r o m e t r y 
(ESI-MS); samples 
were ionized 
with 10 mM ammonium acetate in 
positive ion mode and detected by 
the spectrometer. This ionization 
produced the charge state [M+NH4]+. 
To ensure accuracy, single ion 
monitoring (SIM) mode was used to 
exclusively detect fucose and glucose 
ions.
Two methods were used to 
determine fucose concentrations by 
LC-MS. The first method, a calibration 
curve, related the concentrations of 
fucose solutions to the peak areas they 
produced in the LC-MS chromatogram. 
Fucose standards of 400 μM, 800 μM, 
1200 μM, and 1600 μM were run 
through LC-MS, and their peak areas 
were plotted versus concentration, 
producing a calibration curve (Figure 
8). Concentrations of unknown 
samples were found by running them 
through LC-MS to find a peak area for 
the solution, then extrapolating the 
concentration from the calibration 
curve. 
The second method of 
quantitation utilized a similar sugar, 
glucose, as an internal standard. A 
spike of glucose was injected into a 
fucose standard. A response factor 
Figure	7.	This	HPLC-PAD	chromatogram	depicts	1000μM	fucose,	
which comes off the amino column at approximately 2.5 minutes 
to produce the peak. 
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Figure 8. A 
calibration curve 
was made using four 
standard solutions of 
fucose ranging from 
400	μM	to	1600	μM	
run on the LC-MS. 
The peak area from 
LC increased linearly 
with concentration, 
as the line suggests. 
Concentration was 
plotted versus peak 
area.
Figure 9. LC-MS 
chromatogram. 
Glucose was used as 
an internal standard 
for fucose. By spiking 
in a known amount of 
glucose, the unknown 
concentration of 
fucose could be 
calculated based on 
relative peak areas. 
This particular 
chromatogram 
shows an unknown 
concentration 
of fucose, which 
was accurately 
determined using the 
internal standard 
method. 
Figure 10. Fucose 
Calibration Curve 
prepared by HPLC-
PAD. The Calibration 
curve was produced 
by serial dilutions of 
a	2000	μM	solution.		
The curve shows 
strong correlation 
between fucose 
concentration and 
integrated detector 
response.
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was calculated, which is a way 
to measure how the instrument 
responds to the two sugars. The 
response factor relates the peak areas 
produced by the two different sugars 
to their concentrations; this response 
factor can then be used to calculate 
an unknown fucose concentration 
when glucose has been added. Once 
unknown fucose samples were spiked 
with glucose and run through the 
LC-MS, the previously determined 
response factor was plugged into a 
formula to calculate the concentration 
of fucose (Figure 9).
RESULTS, DISCUSSION AND 
IMPLICATIONS 
Rapid	Methods
The Yellow Card and CRS tests 
were performed on the “unknown” 
fucose solutions. The Yellow Card 
method produced estimates of 900 
μM for unknown 1 and 1400 μM 
for unknown 2.  The Yellow Card 
estimates differed by 3.5% and 
6.5%, respectively, from the actual 
concentrations of the solutions 
(unknown 1 was 933 μM; unknown 2 
was 1314 μM). The CRS test produced 
estimates of 950 μM for unknown 1 
and 1400 μM for unknown 2, differing 
by 1.8% and 6.5%, respectively, from 
the actual concentrations. These 
results suggest that the Yellow Card 
and CRS tests are sufficiently sensitive 
to determine whether fucose levels 
are normal or elevated.
Instrumental	Methods
The fucose concentrations in the 
unknown samples were calculated 
to be 888.7 μM and 1227 μM by 
extrapolation from the HPLC-PAD 
calibration curve (Figure 10).  Both 
of the instrumentally determined 
concentrations were within 7% of 
their actual values.  
After fucose standards were run 
on the LC-MS, two fucose samples 
of unknown concentrations were 
studied. The first unknown gave a 
fucose peak area of 671042.9, which 
correlated to 949.5 ± 18.62 μM from 
the calibration curve and 970.84 μM 
from the internal standard. The actual 
concentration of fucose was 933 μM, 
yielding calibration curve and internal 
standard errors of 1.7% and 3.4%, 
respectively. The second unknown 
gave a fucose peak area of 945248.6, 
which correlated to 1339 ± 18.62 μM 
from the calibration curve and 1319.7 
μM from the internal standard. The 
actual concentration of fucose was 
1314 μM, yielding calibration curve 
and internal standard error of 1.9% 
and 0.38%.
From these experimental tests, it 
was accepted that LC-MS was sensitive 
enough to quantify the levels of fucose 
and accurately classify them as normal, 
precancerous, or cancerous. These 
results imply that LC-MS produces 
sufficiently sensitive data to verify the 
results of the colorimetric methods.
 
CONCLUSIONS
The two unknown solutions 
were tested with each of the methods. 
Results indicate that LC-MS provides 
the most accurate quantitative results, 
as error was less than 3.9%. HPLC-PAD 
was also able to quantify unknown 
samples with 7% error. LC-MS is 
useful for quantifying fucose and it 
provides mass-specific information 
that could be beneficial for identifying 
compounds in a biological sample. 
The two rapid methods successfully 
identified the unknowns as normal, 
precancerous, or cancerous levels 
of fucose. The Yellow Card method 
is advantageous because it requires 
no heat and provides a lasting color 
solRution that can easily be identified 
using the Yellow Card.  It is promising 
for application in a clinical setting 
because it provides quick, visual 
results. 
Successful classification of fucose 
levels as normal, precancerous, or 
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cancerous by both of the rapid methods 
implies that, upon further development, 
these methods may one day be applied to 
a clinical setting. For these experiments, 
pure fucose was analyzed to verify 
our proposed methods. Because these 
simple methods are not selective 
for fucose, any future experiments 
mimicking a biological system would 
also require separation of fucose and/
or fucosylated glycoproteins from other 
sugars in blood or serum. 
The results for the instrumental 
methods and the rapid methods agree. 
Although the Yellow Card method and 
the CRS method had high limits of 
detection, they are still useful methods 
for the early detection of possibly 
cancerous or precancerous conditions. 
Further experimentation could focus 
on reducing the amounts of reactants 
needed as well as modifying the Yellow 
Card method to require less hazardous 
reagents.  
The next step for the project 
involves studying model biological 
systems. Solutions containing both 
sugar and glycoproteins should be 
analyzed with each of the methods 
to more closely mimic a blood or 
serum sample. This would determine 
whether the biological matrix affects 
visualization or quantitation. After 
studies of model systems, separation 
of fucose from biological samples, 
such as blood or serum, could be 
applied towards a clinical setting after 
development of additional preparation 
and purification steps.
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